-
Arikawa J, Schmaljohn AL, Dalrymple JM, Schmaljohn CS, 1989: Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies[J]. J Gen Virol, 70, 615-624.
-
Bi Z, Formenty PB, Roth CE, 2008: Hantavirus infection: a review and global update[J]. J Infect Dev Ctries, 2, 3-23.
-
Chen H, Tang L, Luo Z, Zhang J, Zhang Z, Hu M, Weng J, Liu W, Zhao T, Liu W, 2000: Preventive effects of three kinds of inactive vaccines against epidemic hemorrhagic fever (EHF) after 5 years of vaccination[J]. Zhonghua Liu Xing Bing Xue Za Zhi, 21, 347-348.
-
Chu YK, Jennings G, Schmaljohn A, Elgh F, Hjelle B, Lee HW, Jenison S, Ksiazek T, Peters CJ, Rollin P, 1995: Cross-neutralization of hantaviruses with immune sera from experimentally infected animals and from hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome patients[J]. . J Infect Dis, 172, 1581-1584. doi: 10.1093/infdis/172.6.1581
-
de Carvalho Nicacio C, Lundkvist A, Sjolander KB, Plyusnin A, Salonen EM, Bjorling E, 2000: A neutralizing recombinant human antibody Fab fragment against Puumala hantavirus[J]. J Med Virol, 60, 446-454. doi: 10.1002/(SICI)1096-9071(200004)60:4<446::AID-JMV13>3.0.CO;2-V
-
Guardado-Calvo P, Bignon EA, Stettner E, Jeffers SA, Perez-Vargas J, Pehau-Arnaudet G, Tortorici MA, Jestin JL, England P, Tischler ND, Rey FA, 2016: Mechanistic insight into bunyavirus-induced membrane fusion from structure-function analyses of the hantavirus envelope glycoprotein Gc[J]. PLoS Pathog, 12, e1005813-. doi: 10.1371/journal.ppat.1005813
-
Horling J, Lundkvist A, 1997: Single amino acid substitutions in Puumala virus envelope glycoproteins G1 and G2 eliminate important neutralization epitopes[J]. Virus Res, 48, 89-100. doi: 10.1016/S0168-1702(97)01436-6
-
Jonsson CB, Figueiredo LT, Vapalahti O, 2010: A global perspective on hantavirus ecology, epidemiology, and disease[J]. Clin Microbiol Rev, 23, 412-441.
-
Khaiboullina SF, Morzunov SP, St Jeor SC, 2005: Hantaviruses: molecular biology, evolution and pathogenesis[J]. Curr Mol Med, 5, 773-790. doi: 10.2174/156652405774962317
-
Kikuchi M, Yoshimatsu K, Arikawa J, Yoshida R, Yoo YC, Isegawa Y, Yamanishi K, Tono-oka S, Azuma I, 1998: Characterization of neutralizing monoclonal antibody escape mutants of Hantaan virus 76118[J]. Arch Virol, 143, 73-83. doi: 10.1007/s007050050269
-
Koch J, Liang M, Queitsch I, Kraus AA, Bautz EK, 2003: Human recombinant neutralizing antibodies against hantaan virus G2 protein[J]. Virology, 308, 64-73. doi: 10.1016/S0042-6822(02)00094-6
-
Kruger DH, Schonrich G, Klempa B, 2011: Human pathogenic hantaviruses and prevention of infection[J]. Hum Vaccin, 7, 685-693. doi: 10.4161/hv.7.6.15197
-
Lee PW, Gibbs CJ Jr, Gajdusek DC, Yanagihara R, 1985: Serotypic classification of hantaviruses by indirect immunofluorescent antibody and plaque reduction neutralization tests[J]. J Clin Microbiol, 22, 940-944. doi: 10.1128/JCM.22.6.940-944.1985
-
Li S, Rissanen I, Zeltina A, Hepojoki J, Raghwani J, Harlos K, Pybus OG, Huiskonen JT, Bowden TA, 2016: A molecular-level account of the antigenic hantaviral surface[J]. Cell Rep, 16, 278-. doi: 10.1016/j.celrep.2016.06.039
-
Li W, Cao S, Zhang Q, Li J, Zhang S, Wu W, Qu J, Li C, Liang M, Li D, 2017: Comparison of serological assays to titrate Hantaan and Seoul hantavirus-specific antibodies[J]. Virol J, 14, 133-. doi: 10.1186/s12985-017-0799-0
-
Lin H, Zhang Z, Lu L, Li X, Liu Q, 2014: Meteorological factors are associated with hemorrhagic fever with renal syndrome in Jiaonan County, China, 2006-2011[J]. Int J Biometeorol, 58, 1031-1037. doi: 10.1007/s00484-013-0688-1
-
Liu W, Xu X, Ruan Y, Weng S, Liu W, Zhou W, Dong G, Gu H, Zhu Z, Xu Z, 2000: Safety and immunogenicity of inactivated bivalent EHF vaccine in humans[J]. Zhonghua Liu Xing Bing Xue Za Zhi, 21, 445-447.
-
Lu X, Yin W, Yang Q, Lei Y, Yang J, Sun M, Yao M, Xu Z, Xue X, 2009: Identification of oligopeptides mimicking the receptor-binding domain of Hantaan virus envelope glycoprotein from a phage-displayed peptide library[J]. Can J Microbiol, 55, 664-671. doi: 10.1139/W09-012
-
Maes P, Keyaerts E, Li S, Nlandu-Masunda V, Clement J, Van Ranst M, 2009: Replication reduction neutralization test, a quantitative RT-PCR-based technique for the detection of neutralizing hantavirus antibodies[J]. J Virol Methods, 159, 295-299. doi: 10.1016/j.jviromet.2009.04.006
-
Maes P, Adkins S, Alkhovsky SV, Avsic-Zupanc T, Ballinger MJ, Bente DA, Beer M, Bergeron E, Blair CD, Briese T, Buchmeier MJ, Burt FJ, Calisher CH, Charrel RN, Choi IR, Clegg JCS, de la Torre JC, de Lamballerie X, DeRisi JL, Digiaro M, Drebot M, Ebihara H, Elbeaino T, Ergunay K, Fulhorst CF, Garrison AR, Gao GF, Gonzalez JJ, Groschup MH, Gunther S, Haenni AL, Hall RA, Hewson R, Hughes HR, Jain RK, Jonson MG, Junglen S, Klempa B, Klingstrom J, Kormelink R, Lambert AJ, Langevin SA, Lukashevich IS, Marklewitz M, Martelli GP, Mielke-Ehret N, Mirazimi A, Muhlbach HP, Naidu R, Nunes MRT, Palacios G, Papa A, Paweska JT, Peters CJ, Plyusnin A, Radoshitzky SR, Resende RO, Romanowski V, Sall AA, Salvato MS, Sasaya T, Schmaljohn C, Shi X, Shirako Y, Simmonds P, Sironi M, Song JW, Spengler JR, Stenglein MD, Tesh RB, Turina M, Wei T, Whitfield AE, Yeh SD, Zerbini FM, Zhang YZ, Zhou X, Kuhn JH, 2019: Taxonomy of the order Bunyavirales: second update 2018[J]. Arch Virol, 164, 927-941. doi: 10.1007/s00705-018-04127-3
-
Matumoto M, 1949: A note on some points of calculation method of LD50 by Reed and Muench[J]. Jpn J Exp Med, 20, 175-9-175-179.
-
McCaughey C, Hart CA, 2000: Hantaviruses[J]. J Med Microbiol, 49, 587-599. doi: 10.1099/0022-1317-49-7-587
-
Meyer BJ, Schmaljohn CS, 2000: Persistent hantavirus infections: characteristics and mechanisms[J]. Trends Microbiol, 8, 61-67. doi: 10.1016/S0966-842X(99)01658-3
-
Muyangwa M, Martynova EV, Khaiboullina SF, Morzunov SP, Rizvanov AA, 2015: Hantaviral proteins: structure, functions, and role in hantavirus infection[J]. Front Microbiol, 6, 1326-.
-
Pastrana DV, Buck CB, Pang YY, Thompson CD, Castle PE, FitzGerald PC, Kruger Kjaer S, Lowy DR, Schiller JT, 2004: Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18[J]. Virology, 321, 205-216. doi: 10.1016/j.virol.2003.12.027
-
Schmaljohn C, Hjelle B, 1997: Hantaviruses: a global disease problem[J]. Emerg Infect Dis, 3, 95-104. doi: 10.3201/eid0302.970202
-
Song G, Hang CS, Liao HX, Fu JL, Gao GZ, Qiu HL, Zhang QF, 1984: Antigenic difference between viral strains causing classical and mild types of epidemic hemorrhagic fever with renal syndrome in China[J]. J Infect Dis, 150, 889-894. doi: 10.1093/infdis/150.6.889
-
Song JY, Woo HJ, Cheong HJ, Noh JY, Baek LJ, Kim WJ, 2016: Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (Hantavax) in healthy adults[J]. Vaccine, 34, 1289-1295. doi: 10.1016/j.vaccine.2016.01.031
-
Tang YW, Li YL, Ye KL, Xu ZY, Ruo SL, Fisher-Hoch SP, McCormick JB, 1991: Distribution of hantavirus serotypes Hantaan and Seoul causing hemorrhagic fever with renal syndrome and identification by hemagglutination inhibition assay[J]. J Clin Microbiol, 29, 1924-1927. doi: 10.1128/JCM.29.9.1924-1927.1991
-
Vaheri A, Strandin T, Hepojoki J, Sironen T, Henttonen H, Makela S, Mustonen J, 2013: Uncovering the mysteries of hantavirus infections[J]. Nat Rev Microbiol, 11, 539-550. doi: 10.1038/nrmicro3066
-
Watson DC, Sargianou M, Papa A, Chra P, Starakis I, Panos G, 2014: Epidemiology of Hantavirus infections in humans: a comprehensive, global overview[J]. Crit Rev Microbiol, 40, 261-272. doi: 10.3109/1040841X.2013.783555
-
Willensky S, Bar-Rogovsky H, Bignon EA, Tischler ND, Modis Y, Dessau M, 2016: Crystal structure of glycoprotein c from a hantavirus in the post-fusion conformation[J]. PLoS Pathog, 12, e1005948-. doi: 10.1371/journal.ppat.1005948
-
Yan G, Zhang Y, Ma Y, Yi J, Liu B, Xu Z, Zhang Y, Zhang C, Zhang F, Xu Z, Yang A, Zhuang R, Jin B, 2012: Identification of a novel B-cell epitope of Hantaan virus glycoprotein recognized by neutralizing 3D8 monoclonal antibody[J]. J Gen Virol, 93, 2595-2600. doi: 10.1099/vir.0.045302-0
-
Zhang XK, Takashima I, Hashimoto N, 1989: Characteristics of passive immunity against hantavirus infection in rats[J]. Arch Virol, 105, 235-246. doi: 10.1007/BF01311360
-
Zhang S, Wang S, Yin W, Liang M, Li J, Zhang Q, Feng Z, Li D, 2014: Epidemic characteristics of hemorrhagic fever with renal syndrome in China, 2006-2012[J]. BMC Infect Dis, 14, 384-. doi: 10.1186/1471-2334-14-384
-
Zou LX, Chen MJ, Sun L, 2016: Haemorrhagic fever with renal syndrome: literature review and distribution analysis in China[J]. Int J Infect Dis, 43, 95-100. doi: 10.1016/j.ijid.2016.01.003